IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

Glenmark Pharmaceuticals

NSE:GLENMARK · ISIN INE935A01035

Close
₹2,261.7
29 Jul 2026
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Glenmark Pharmaceuticals

Filings

Preserved evidence

Primary-source filing timeline

40 recent events
Press Release - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing
Copy of Newspaper Publication - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing
Analysts/Institutional Investor Meet/Con. Call Updates - Glenmark Pharmaceuticals LimitedNSE · conference call · pdf
Source filing
Press Release - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Board Meeting Intimation for Considering And Approving Unaudited Financial Results Of Glenmark Pharmaceuticals Limited For The Quarter Ended June 30, 2026BSE · financial results · pdf
Archived filing
Press Release - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing
Press Release - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing
General Updates - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing
Analysts/Institutional Investor Meet/Con. Call Updates - Glenmark Pharmaceuticals LimitedNSE · conference call · pdf
Source filing
Trading Window - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing
Press Release - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing
Press Release - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing
Investor Presentation - Glenmark Pharmaceuticals LimitedNSE · investor presentation · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing
Press Release - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Source filing
Analysts/Institutional Investor Meet/Con. Call Updates - Glenmark Pharmaceuticals LimitedNSE · conference call · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Corporate Action-Board to consider DividendBSE · corporate action · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Board Meeting Outcome for Audited Financial Results And Recommendation Of Final DividendBSE · financial results · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Transfer Of Company''s Nebulizer BrandBSE · exchange filing · pdf
Source filing
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing
Dividend - Glenmark Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing
Outcome of Board Meeting - Glenmark Pharmaceuticals LimitedNSE · financial results · pdf
Source filing